跳至主要内容
临床试验/NCT02103595
NCT02103595已完成不适用

Perception of Insertion Pain With Soft Cannula Infusion Sets: A Multicenter, Randomized, Cross-over Study to Evaluate Accu-Chek FlexLink Plus and Accu-Chek FlexLink Under Real Life Conditions.

Hoffmann-La Roche5 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2013年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
5
主要终点
Perception of pain during infusion set insertion assessed by means of a visual analogue scale (VAS)

研究概览

简要总结

German Multi-centered, randomized, crossover study in diabetic patients evaluating two infusion sets under real life conditions at home. Subjects will be randomized to use one of the infusion set devices during the first period of 4 weeks, and be switched to the other infusion set for the second period of 4 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female subjects at least 18 years of age
  • Diabetes mellitus type 1 or type 2
  • Continuous subcutaneous insulin therapy (CSII) for at least 3 months
  • Insulin pump compatible with Luer lock infusion set (Accu-Chek, Disetronic, Animas, Deltec Cozmo and Minimed 506 to 508)
  • Sufficient potential infusion sites suitable for the usage of a cannula length of 8 mm and a tubing length of 70 and 80 cm
  • Willing to measure blood glucose at least 4 times per day and 1-3 hrs after each new insertion
  • Willing and able to participate and comply with study procedures including the general recommendation of shifting infusion sets (at least every 3 days)

排除标准

  • Significantly impaired awareness of hypoglycemia
  • A history of or high risk of ketoacidosis during CSII therapy
  • Frequent catheter abscesses in the past year, as per investigator´s discretion
  • Known strong plaster incompatibility and/or allergy (history of catheter use)
  • Unstable chronic disease other than diabetes
  • Chronic use of steroids in adrenal suppressive doses, other immuno-modulatory medication or chemotherapy
  • Acute illness or abnormality at the time of screening rendering the patient not suitable to participate in the study in the opinion of the Investigator
  • Chronic use of analgesics and any other condition interfering with the assessment of pain, as per investigator´s discretion
  • Are either pregnant or breastfeeding or are currently planning a pregnancy

结局指标

主要结局

Perception of pain during infusion set insertion assessed by means of a visual analogue scale (VAS)

时间窗: 8 weeks

次要结局

  • Incidence of adverse events(8 weeks)
  • Insulin set replacement pattern(8 weeks)
  • Incidence of kinked cannulas(8 weeks)
  • Pump settings, including insulin dosage(8 weeks)
  • Device satisfaction/preference as assessed by patient surveys(8 weeks)
  • Investigator assessment of patient device use(At Baseline and Week 4)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验